How does a cell know when it’s been damaged? A molecular alarm, set off by mutated RNA and colliding ribosomes, signals ...

Valued at $13 billion by market cap, Cambridge, Massachusetts-based Moderna, Inc. (MRNA) operates as a clinical-stage ...

our findings show how RNA may directly contribute to the stability and evolution of the genome. It's not merely a passive messenger, but an active participant in genome maintenance. These insights ...

Because they rely on hosts for a majority of functions, viruses aren’t considered alive. But entities like this one ...

Under the agreement, Allarity will supply advanced transcriptome analysis services to support the partner’s efforts to ...

The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.

To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...

A Ph.D. graduate student in biomolecular engineering at UC Santa Cruz, with a background in computer science and mathematics, ...

The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...

The approval comes amid regulatory upheaval under HHS head Robert F. Kennedy Jr., who has pushed for changes around mRNA ...

Moderna (MRNA) stock rises as the company's Spikevax COVID-19 vaccine gets FDA approval for kids 6 months-11 years at higher ...

Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...